FIG A3.
AR-V7 detection in circulating tumor cells (CTCs) and its association with resistance to androgen receptor (AR)–directed therapy in the present cohort. Proportion of patients with AR-V7 detected (n = 2) or not (n = 23) in circulating tumor cells who developed resistance or not to AR-directed therapy are shown. The positive predictive value (PPV) and negative predictive value (NPV) are displayed in each panel. P values were calculated using Fisher’s exact test. AR, androgen receptor.